Skip to content
  2. Monarch research institute

Monarch Research Institute

Further expanding our understanding of emerging treatments to help more patients recover from mental health conditions.
Rectangle 114
MonarchResearchGroup

Led by Professor Paul Fitzgerald and Associate Professor Bernadette Fitzgibbon, Monarch Research Institute is the engine of the Monarch Mental Health Group. This extension pursues the discovery of new frontiers within the Australian mental health landscape and forms the evidence-based foundations for emerging treatments and patient experiences.

Current areas of focus include:

  • Neurostimulation,
  • Ketamine.

Brain Stimulation Trials 

Our brain stimulation clinical trials aim to optimise the application of transcranial magnetic stimulation in the treatment of people diagnosed with treatment-resistant major depressive disorder.  

 

These trials run through our clinical TMS program. Participants will be recruited through referrals from treating clinicians and from patients presenting for TMS therapy to the clinics of Monarch Mental Health Group. Participants eligible for the research trials will receive a standard depression TMS treatment plus a potential additional element. 

 

If you are interested in hearing more about our brain stimulation trials, please email us at MonarchResearchInstitute@mmhg.com.au 

 

 

Clinical Trials

Contact us for more information about our clinical trials program.